CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*

The use of primary hepatocytes is now well established for both studies of drug metabolism and enzyme induction. Cryopreservation of primary hepatocytes decreases the need for fresh liver tissue. This is especially important for research with human hepatocytes because availability of human liver tissue is limited. In this review, we summarize our research on optimization and validation of cryopreservation techniques. The critical elements for successful cryopreservation of hepalocytes are (1) the freezing protocol, (2) the concentration of the cryoprotectant [10% dimethylsulfoxide (DMSO)], (3) slow addition and removal of DMSO, (4) carbogen equilibration during isolation of hepatocytes and before cryopreservation, and (5) removal of unvital hepatocytes by Percoll centrifugation after thawing. Hepatocytes of human, monkey, dog, rat, and mouse isolated and cryopreserved by our standard procedure have a viability ≥ 80%. Metabolic capacity of cryopreserved hepatocytes determined by testosterone hydroxylation, 7-ethoxyresorufin-O-de-ethylase (EROD), 7-ethoxycoumarin-O-deethylase (ECOD), glutathione S-transferase, UDP-glucuronosyl transferase, sulfotransferase, and epoxide hydrolase activities is ≥60% of freshly isolated cells. Cryopreserved hepatocytes in suspension were successfully applied in short-term metabolism studies and as a metabolizing system in mutagenicity investigations. For instance, the complex pattern of benzo[a]pyrene metabolites including phase II metabolites formed by freshly isolated and cryopreserved hepatocytes was almost identical. For the study of enzyme induction, a longer time period and therefore cryopreserved hepatocyte cultures are required. We present a technique with cryopreserved hepatocytes that allows the induction of testosterone metabolism with similar induction factors as for fresh cultures. However, enzyme activities of induced hepatocytes and solvent controls were smaller in the cryopreserved cells. In conclusion, cryopreserved hepatocytes held in suspension can be recommended for short-term metabolism or toxicity studies. Systems with cryopreserved hepatocyte cultures that could be applied for studies of enzyme induction are already in a state allowing practical application, but may be further optimized.

[1]  G. Siest,et al.  UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. , 1983, Biochemical pharmacology.

[2]  Walter A. Korfmacher,et al.  Metabolism of methapyrilene by Fischer-344 rat and B6C3F1 mouse hepatocytes. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  B J Blaauboer,et al.  Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. , 1991, Biochemical pharmacology.

[4]  F. Oesch,et al.  A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics. , 1993, Cryobiology.

[5]  F. Oesch,et al.  Cultures with cryopreserved hepatocytes: applicability for studies of enzyme induction. , 2000, Chemico-biological interactions.

[6]  G. L. Kedderis,et al.  Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. , 1999, Chemico-biological interactions.

[7]  F. Oesch,et al.  Cryopreserved and hypothermically stored rat liver parenchymal cells as metabolizing system in the Salmonella mutagenicity assay. , 1995, Mutation research.

[8]  B. Lacarelle,et al.  Thawed human hepatocytes in primary culture. , 1992, Cryobiology.

[9]  J. Caldwell,et al.  Cryopreservation of rat and mouse hepatocytes. I. Comparative viability studies. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[10]  A. Guillouzo,et al.  Long-term maintenance of drug-metabolizing enzyme activities in rat hepatocytes after cryopreservation. , 1997, Toxicology and applied pharmacology.

[11]  D. Utesch,et al.  Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  F. Oesch,et al.  Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. , 1980, Biochemical pharmacology.

[13]  K. Carroll,et al.  Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[14]  F. Oesch,et al.  Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension. , 1999, Drug Metabolism And Disposition.

[15]  F. Oesch,et al.  Direct Analysis of Phase I Metabolites, Phenol Sulfates, Glucuronides and Glutathione Conjugates of Benzo[a]pyrene in Freshly Isolated, Hypothermically Stored and Cryopreserved Hepatocytes , 1996 .

[16]  A. Guillouzo,et al.  Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes. , 1996, Toxicology and applied pharmacology.

[17]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.

[18]  H. Glatt,et al.  Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives. , 1987, Cancer research.

[19]  F. Schildberg,et al.  Cryopreservation of porcine hepatocyte cultures. , 1996, Cryobiology.

[20]  Mehmet Toner,et al.  A Stable Long‐Term Hepatocyte Culture System for Studies of Physiologic Processes: Cytokine Stimulation of the Acute Phase Response in Rat and Human Hepatocytes , 1992, Biotechnology progress.

[21]  M K Bayliss,et al.  7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  F. Oesch,et al.  Characterization of cryopreserved rat liver parenchymal cells by metabolism of diagnostic substrates and activities of related enzymes. , 1992, Biochemical pharmacology.

[23]  F. Oesch,et al.  Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. , 1992, Journal of chromatography.

[24]  G Smith,et al.  A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. , 1994, Biochemical pharmacology.

[25]  M. Grant,et al.  Cryopreservation of rat hepatocyte monolayer cultures , 1996, Human & experimental toxicology.

[26]  H. Sohn,et al.  Modulation of cytochrome P-450 induction by long-term food restriction in male rats. , 1994, Biochemistry and molecular biology international.

[27]  J. Caldwell,et al.  Cryopreservation of rat and mouse hepatocytes. II. Assessment of metabolic capacity using testosterone metabolism. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[28]  A. Li,et al.  Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. , 1997, Chemico-biological interactions.

[29]  H. Roh,et al.  Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns. , 1998, Chemico-biological interactions.

[30]  M. Cayen,et al.  Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice. , 1992, Biochemical pharmacology.

[31]  V. Rogiers,et al.  Maintenance and induction in co-cultured rat hepatocytes of components of the cytochrome P450-mediated mono-oxygenase. , 1993, Biochemical pharmacology.

[32]  J. Silva,et al.  Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. , 1999, Chemico-biological interactions.

[33]  A. Li,et al.  Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions. , 1997, Advances in pharmacology.